Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Jun;271(6):3328-3339.
doi: 10.1007/s00415-024-12228-0. Epub 2024 Mar 13.

Moyamoya disease in Southeast Asians: genetic and autopsy data, new cases, systematic review, and meta-analysis of all patients from the literature

Affiliations
Meta-Analysis

Moyamoya disease in Southeast Asians: genetic and autopsy data, new cases, systematic review, and meta-analysis of all patients from the literature

Daniel Strunk et al. J Neurol. 2024 Jun.

Abstract

Background: Moyamoya disease (MMD) is a rare disorder causing ischemic and hemorrhagic juvenile stroke. It is associated with the founder susceptibility variant p.R4810K in the RNF213 gene in East Asia. Our aim was to enhance understanding of MMD in so far poorly characterized Southeast Asians and exploring differences with Caucasian Europeans.

Methods: By retrospective analysis of medical records and systematic database search on PubMed for all published cases, we identified Southeast Asian patients with MMD. We extracted and pooled proportions using fixed-effects models. Our own cohort was tested for the East Asian RNF213 founder variant p.R4810K. One of our Southeast Asian patients underwent post-mortem histopathological examination.

Results: The study cohort comprised 32 Southeast Asians. Mean age at onset in the entire cohort was 32.5 ± 20.3 years (n = 24), 43.4 ± 8.7 years in patients admitted to our center (n = 11), and 23.4 ± 22.4 years in patients from the international literature (n = 13). Female-to-male ratio was 1.6:1. MMD predominantly affected bilateral anterior intracranial vessels. Cerebral ischemia outnumbered transient ischemic attacks (TIAs) and intracranial hemorrhage. TIAs, arterial hypertension and obesity were significantly less frequent in Southeast Asian patients compared to Caucasian Europeans. p.R4810K was absent in all examined Southeast Asians despite of typical histopathological signs of MMD in one autopsy case.

Conclusion: Clinical and histopathological manifestations of MMD in Southeast Asians are similar to those in Caucasian Europeans. The genotype of MMD in Southeast Asians differs from that of most East Asian patients.

Keywords: RNF213 p.R4810K variant; East Asian; European Caucasian; Histopathology; Moyamoya disease; Southeast Asian.

PubMed Disclaimer

Conflict of interest statement

Daniel Strunk: There is no conflict of interest. Peter Bauer: is chief medical and genomic officer at Centigene AG Rostock. Kathy Keyvani: There is no conflict of interest. Rolf R. Diehl: There is no conflict of interest. Roland Veltkamp: RV is an investigator of the NIHR Imperial Biomedical Research Centre and reports fees for consulting and speaker honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Pfizer, Daichi Sankyo, Portola, Biogen, Medtronic, and Morphosys; and research grants from Bayer, Boehringer, Bristol Myers Squibb. Peter Berlit: There is no conflict of interest. Sven G. Meuth: There is no conflict of interest. Lars Timmermann: LT reports grants, personal fees, and non-financial support from SAPIENS Steering Brain Stimulation, Medtronic, Boston Scientific, and St. Jude Medical, and has received payments from Bayer Healthcare, UCB Schwarz Pharma, and Archimedes Pharma and also honoraria as a speaker on symposia sponsored by Teva Pharma, Lundbeck Pharma, Bracco, Gianni PR, Medas Pharma, UCB Schwarz Pharma, Desitin Pharma, Boehringer Ingelheim, GSK, Eumecom, Orion Pharma, Medtronic, Boston Scientific, Cephalon, Abbott, GE Medical, Archimedes, and Bayer. Jan Claudius Schwitalla: JCS is a full-time employee of Astra Zenica, but this article was written as part of his voluntary work on the board of the German Moyamoya Association. Markus Kraemer: MK received honoraria for lecture activities from Roche Pharma and Chugai without any connection to the topic of the article.

Figures

Fig. 1
Fig. 1
Flowchart of the literature search
Fig. 2
Fig. 2
Histopathological staining of the internal carotid artery of a deceased female Thai Moyamoya patient: A high-grade Moyamoya pathology in the form of thickening and undulation and partly Duplication or triplication of the internal elastic membrane (white arrow) (Elastica van Gieson staining); B fibrocellular thickening and smooth muscle cell proliferation of the tunica intima (actin staining) (black star)

Similar articles

Cited by

References

    1. Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis) Neurol Med Chir (Tokyo) 2012;52:245–266. doi: 10.2176/nmc.52.245. - DOI - PubMed
    1. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226–1237. doi: 10.1056/NEJMra0804622. - DOI - PubMed
    1. Mertens R, Graupera M, Gerhardt H, et al. The genetic basis of moyamoya disease. Transl Stroke Res. 2022;13:25–45. doi: 10.1007/s12975-021-00940-2. - DOI - PMC - PubMed
    1. Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79:900–904. doi: 10.1136/jnnp.2007.130666. - DOI - PubMed
    1. Ahn IM, Park D-H, Hann HJ, et al. Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke. 2014;45:1090–1095. doi: 10.1161/STROKEAHA.113.004273. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources